Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Lothar Kanz

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Anatomy

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Physiology

Hematopoiesis

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
82
Bokemeyer, Carsten
78
Brugger, Wolfram
69
Hartmann, Jörg Thomas
38
Kollmannsberger, Christian
33
Mertelsmann, Roland
31
Einsele, Hermann
26
Brossart, Peter
25
Hebart, Holger
24
Bühring, Hans-Jörg
23
Möhle, Robert
22
Beyer, Jörg
21
Scheding, Stefan
19
Mayer, Frank
18
Grünebach, Frank
18
Kötter, Ina

Sign-in to see all Coauthors

Publications

TOP 3
Lengerke Claudia; Grauer Matthias; Niebuhr Nina I; Riedt Tamara; Kanz Lothar; Park In-Hyun; Daley George Q
Hematopoietic development from human induced pluripotent stem cells.
Drost Adriana C; Weng Sibylle; Feil Gerhard; Schäfer Jochen; Baumann Simon; Kanz Lothar; Sievert Karl-Dietrich; Stenzl Arnulf; Möhle Robert
In vitro myogenic differentiation of human bone marrow-derived mesenchymal stem cells as a potential treatment for urethral sphincter muscle repair.
Weisel Katja C; Dick John; Fibbe Willem E; Kanz Lothar
International Symposium and Workshop on hematopoietic stem cells VII, University of Tübingen, Germany, September 18-20, 2008.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Lothar Kanz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Lengerke Claudia; Grauer Matthias; Niebuhr Nina I; Riedt Tamara; Kanz Lothar; Park In-Hyun; Daley George Q
Hematopoietic development from human induced pluripotent stem cells.
Annals of the New York Academy of Sciences 2009;1176():219-27.
2009: Drost Adriana C; Weng Sibylle; Feil Gerhard; Schäfer Jochen; Baumann Simon; Kanz Lothar; Sievert Karl-Dietrich; Stenzl Arnulf; Möhle Robert
In vitro myogenic differentiation of human bone marrow-derived mesenchymal stem cells as a potential treatment for urethral sphincter muscle repair.
Annals of the New York Academy of Sciences 2009;1176():135-43.
2009: Weisel Katja C; Dick John; Fibbe Willem E; Kanz Lothar
International Symposium and Workshop on hematopoietic stem cells VII, University of Tübingen, Germany, September 18-20, 2008.
Annals of the New York Academy of Sciences 2009;1176():1-17.
2009: Boehmler Andreas M; Drost Adriana; Jaggy Lena; Seitz Gabriele; Wiesner Tina; Denzlinger Claudio; Kanz Lothar; Möhle Robert
The CysLT1 ligand leukotriene D4 supports alpha4beta1- and alpha5beta1-mediated adhesion and proliferation of CD34+ hematopoietic progenitor cells.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(11):6789-98.
2009: Riedt Tamara; Ebinger Martin; Salih Helmut R; Tomiuk Jürgen; Handgretinger Rupert; Kanz Lothar; Grünebach Frank; Lengerke Claudia
Aberrant expression of the homeobox gene CDX2 in pediatric acute lymphoblastic leukemia.
Blood 2009;113(17):4049-51.
2009: Kopp H G; Yildirim S; Weisel K C; Kanz L; Vogel W
Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma.
Journal of cancer research and clinical oncology 2009;135(4):637-42.
2009: Schittenhelm Marcus M; Kollmannsberger Christian; Oechsle Karin; Harlow Amy; Morich Jason; Honecker Friedemann; Kurek Raffael; Störkel Stephan; Kanz Lothar; Corless Christopher L; Wong Kwok-Kin; Bokemeyer Carsten; Heinrich Michael C
Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancer.
Molecular cancer therapeutics 2009;8(3):481-9.
2009: Weisel Katja C; Yildirim Sedat; Schweikle Eric; Kanz Lothar; Möhle Robert
Regulation of FLT3 and its ligand in normal hematopoietic progenitor cells.
Annals of hematology 2009;88(3):203-11.
2009: Weisel Katja C; Moore Malcolm A S; Kanz Lothar; Möhle Robert
Extended in vitro expansion of adult, mobilized CD34+ cells without significant cell senescence using a stromal cell coculture system with single cytokine support.
Stem cells and development 2009;18(2):229-34.
2009: Battula Venkata Lokesh; Treml Sabrina; Bareiss Petra M; Gieseke Friederike; Roelofs Helene; de Zwart Peter; Müller Ingo; Schewe Bernhard; Skutella Thomas; Fibbe Willem E; Kanz Lothar; Bühring Hans-Jörg
Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1.
Haematologica 2009;94(2):173-84.
2009: Pintoffl Jan; Meisinger Ines; Mayer Frank; Horger Marius; von Weyhern Claus; Kanz Lothar; Hartmann Joerg Thomas
Long-term disease stabilization during second-line gemcitabine in a refractory metastatic haemangioendothelioma.
Anti-cancer drugs 2009;20(1):73-4.
2009: Weisel Katja C; Böckeler Michael; Bianchi Leonardo; Terracciano Luigi M; Mayer Frank; Kanz Lothar
Development of rapid light-chain deposition disease in hepatic arteries with severe ischemic cholangitis in a multiple myeloma patient treated with melphalan, prednisone and lenalidomide.
International journal of hematology 2009;89(1):91-4.
2009: Weisel Katja C; Bautz Frank; Seitz Gabriele; Yildirim Sedat; Kanz Lothar; Möhle Robert
Modulation of CXC chemokine receptor expression and function in human neutrophils during aging in vitro suggests a role in their clearance from circulation.
Mediators of inflammation 2009;2009():790174.
2008: Hartmann Jörg Thomas; Kanz Lothar
Sunitinib and periodic hair depigmentation due to temporary c-KIT inhibition.
Archives of dermatology 2008;144(11):1525-6.
2008: Weisel Katja C; Weidmann Eckhart; Anagnostopoulos Ioannis; Kanz Lothar; Pezzutto Antonio; Subklewe Marion
Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphoma.
International journal of hematology 2008;88(4):434-40.
2008: Henes J C; Müller M; Krieger J; Balletshofer B; Pfannenberg A C; Kanz L; Kötter I
[18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis.
Clinical and experimental rheumatology 2008;26(3 Suppl 49):S47-52.
2008: Horger M; Pereira P; Claussen C D; Kanz L; Vonthein R; Denecke B; Driessen C
Hyperattenuating bone marrow abnormalities in myeloma patients using whole-body non-enhanced low-dose MDCT: correlation with haematological parameters.
The British journal of radiology 2008;81(965):386-96.
2008: Sureda Anna; Robinson Stephen; Canals Carmen; Carella Angelo M; Boogaerts Marc A; Caballero Dolores; Hunter Ann E; Kanz Lothar; Slavin Shimon; Cornelissen Jan J; Gramatzki Martin; Niederwieser Dietger; Russell Nigel H; Schmitz Norbert
Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):455-62.
2008: Bethge Wolfgang A; Faul Christoph; Bornhäuser Martin; Stuhler Gernot; Beelen Dietrich W; Lang Peter; Stelljes Matthias; Vogel Wichard; Hägele Matthias; Handgretinger Rupert; Kanz Lothar
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
Blood cells, molecules & diseases 2008;40(1):13-9.
2007: Kötter Ina; Wacker Alexander; Koch Silvia; Henes Jörg; Richter Constanze; Engel Andreas; Günaydin Ilhan; Kanz Lothar
Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
Seminars in arthritis and rheumatism 2007;37(3):189-97.
2007: Haap M; Gallwitz B; Thamer C; Müssig K; Häring H-U; Kanz L; Hartmann J T
Symptomatic hypoglycemia during imatinib mesylate in a non-diabetic female patient with gastrointestinal stromal tumor.
Journal of endocrinological investigation 2007;30(8):688-92.
2007: Mayer Frank; Aebert Hermann; Rudert Maximilian; Königsrainer Alfred; Horger Marius; Kanz Lothar; Bamberg Michael; Ziemer Gerhard; Hartmann Jörg Thomas
Primary malignant sarcomas of the heart and great vessels in adult patients--a single-center experience.
The oncologist 2007;12(9):1134-42.
2007: Hartmann Joerg T; Mayer Frank; Schleicher Jan; Horger Marius; Huober Jens; Meisinger Ines; Pintoffl Jan; Käfer Gabriele; Kanz Lothar; Grünwald Viktor;
Bendamustine hydrochloride in patients with refractory soft tissue sarcoma: a noncomparative multicenter phase 2 study of the German sarcoma group (AIO-001).
Cancer 2007;110(4):861-6.
2007: Kopp Hans-Georg; Horger Marius; Faul Christoph; Hartmann Jorg T; Kanz Lothar; Lang Peter; Vogel Wichard
Granulocyte colony-stimulating factor induced pulmonary hemorrhage in a healthy stem cell donor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(21):3174-5.
2007: Möhle Robert; Kanz Lothar
Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion.
Seminars in hematology 2007;44(3):193-202.
2007: Weisel Katja C; Fibbe Willem E; Kanz Lothar
Meeting summary: International Symposium and Workshop on Hematopoietic Stem Cells VI, University of Tübingen, Germany, September 14-16, 2006.
Experimental hematology 2007;35(7):1005-14.
2007: Brauer Katharina M; Werth Daniela; von Schwarzenberg Karin; Bringmann Anita; Kanz Lothar; Grünebach Frank; Brossart Peter
BCR-ABL activity is critical for the immunogenicity of chronic myelogenous leukemia cells.
Cancer research 2007;67(11):5489-97.
2007: Weisel Katja C; Yildirim Sedat; Schweikle Eric; Kanz Lothar; Möhle Robert
Effect of FLT3 inhibition on normal hematopoietic progenitor cells.
Annals of the New York Academy of Sciences 2007;1106():190-6.
2007: Bühring Hans-Jörg; Battula Venkata Lokesh; Treml Sabrina; Schewe Bernhard; Kanz Lothar; Vogel Wichard
Novel markers for the prospective isolation of human MSC.
Annals of the New York Academy of Sciences 2007;1106():262-71.
2007: Xue Xingkui; Cai Zhen; Seitz Gabriele; Kanz Lothar; Weisel Katja C; Möhle Robert
Differential effects of G protein coupled receptors on hematopoietic progenitor cell growth depend on their signaling capacities.
Annals of the New York Academy of Sciences 2007;1106():180-9.
2007: Hartmann Jörg Thomas; Pintoffl Jan Peter; Al-Batran Salah-Eddin; Quietzsch Detlef; Meisinger Ines; Horger Marius; Nehls Oliver; Bokemeyer Carsten; Königsrainer Alfred; Jäger Elke; Kanz Lothar
Mitomycin C plus infusional 5-fluorouracil in platinum-refractory gastric adenocarcinoma: an extended multicenter phase II study.
Onkologie 2007;30(5):235-40.
2007: Horger Marius; Kanz Lothar; Denecke Barbara; Vonthein Reinhard; Pereira Philippe; Claussen Claus D; Driessen Christoph
The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma.
Cancer 2007;109(8):1617-26.
2007: Schmidt-Hieber M; Blau I W; Trenschel R; Andreesen R; Stuhler G; Einsele H; Kanz L; Keilholz U; Marinets O; Beelen D W; Fauser A A; Volin L; Ruutu T; Uharek L; Fietz T; Knauf W; Hopfenmüller W; Thiel E; Freund M; Casper J
Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma.
Bone marrow transplantation 2007;39(7):389-96.
2007: Balabanov Stefan; Gontarewicz Artur; Ziegler Patrick; Hartmann Ulrike; Kammer Winfried; Copland Mhairi; Brassat Ute; Priemer Martin; Hauber Ilona; Wilhelm Thomas; Schwarz Gerold; Kanz Lothar; Bokemeyer Carsten; Hauber Joachim; Holyoake Tessa L; Nordheim Alfred; Brümmendorf Tim H
Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach.
Blood 2007;109(4):1701-11.
2006: Oechsle Karin; Müller Martin R; Hartmann Jörg T; Kanz Lothar; Bokemeyer Carsten
Aprepitant as salvage therapy in patients with chemotherapy-induced nausea and emesis refractory to prophylaxis with 5-HT(3) antagonists and dexamethasone.
Onkologie 2006;29(12):557-61.
2006: Hartmann Jörg T; Meisinger Ines; Kröber Stefan M; Weisel Katja; Klingel Karin; Kanz Lothar
Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine/cyclophosphamide and rituximab for relapsed B cell lymphoma.
Haematologica 2006;91(12 Suppl):ECR49.
2006: Bethge Wolfgang A; Haegele Matthias; Faul Christoph; Lang Peter; Schumm Michael; Bornhauser Martin; Handgretinger Rupert; Kanz Lothar
Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity.
Experimental hematology 2006;34(12):1746-52.
2006: Knop S; Schupp M; Wardelmann E; Stueker D; Horger M S; Kanz L; Einsele H; Kroeber S M
A new case of Carney triad: gastrointestinal stromal tumours and leiomyoma of the oesophagus do not show activating mutations of KIT and platelet-derived growth factor receptor alpha.
Journal of clinical pathology 2006;59(10):1097-9.
2006: Kopp Hans-Georg; Kanz Lothar; Hartmann Joerg T
Complete remission of relapsing high-grade angiosarcoma with single-agent metronomic trofosfamide.
Anti-cancer drugs 2006;17(8):997-8.
2006: Wassmann Barbara; Pfeifer Heike; Goekbuget Nicola; Beelen Dietrich W; Beck Joachim; Stelljes Matthias; Bornhäuser Martin; Reichle Albrecht; Perz Jolanta; Haas Rainer; Ganser Arnold; Schmid Mathias; Kanz Lothar; Lenz Georg; Kaufmann Martin; Binckebanck Anja; Brück Patrick; Reutzel Regina; Gschaidmeier Harald; Schwartz Stefan; Hoelzer Dieter; Ottmann Oliver G
Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
Blood 2006;108(5):1469-77.
2006: Wierecky Jan; Müller Martin R; Wirths Stefan; Halder-Oehler Edith; Dörfel Daniela; Schmidt Susanne M; Häntschel Maik; Brugger Wolfram; Schröder Stephen; Horger Marius S; Kanz Lothar; Brossart Peter
Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients.
Cancer research 2006;66(11):5910-8.
2006: Kollmannsberger C; Schittenhelm M; Honecker F; Tillner J; Weber D; Oechsle K; Kanz L; Bokemeyer C
A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(6):1007-13.
2006: Hartmann J T; Oechsle K; Huober J; Jakob A; Azemar M; Horger M; Kanz L; Bokemeyer C
An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma.
Investigational new drugs 2006;24(3):249-53.
2006: Stuhler G; Knop S; Topp M S; Kröber S M; Ernemann U; Herrlinger U; Einsele H; Kanz L; Hebart H
Intravenously administered rituximab induces remission of EBV associated non Hodgkin lymphoma confined to the brain in a patient after allogeneic stem cell transplantation.
Haematologica 2006;91(3):ECR01.
2006: Kopp Hans-Georg; Kuczyk Markus; Classen Johannes; Stenzl Arnulf; Kanz Lothar; Mayer Frank; Bamberg Michael; Hartmann Jörg Thomas
Advances in the treatment of testicular cancer.
Drugs 2006;66(5):641-59.
2005: Kötter I; Daikeler T; Amberger C; Tyndall A; Kanz L
Autologous stem cell transplantation of treatment-resistant systemic vasculitis--a single center experience and review of the literature.
Clinical nephrology 2005;64(6):485-9.
2005: Kötter I; Daikeler T; Einsele H; Koch S; Lochmann L; Kanz L; Löffler J
Relapse of autoimmune diseases after autologous T cell depleted stem cell transplantation may be triggered by T cells recently emigrated from the thymus.
Annals of the rheumatic diseases 2005;64(12):1787-9.
2005: Bethge Wolfgang A; Schmalzing Marc; Stuhler Gernot; Schumacher Ulrike; Kröber Stefan-Martin; Horger Marius; Einsele Hermann; Kanz Lothar; Hebart Holger
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
Haematologica 2005;90 Suppl():ECR22.
2005: Knop Stefan; Herrlinger Ulrich; Ernemann Ulrike; Kanz Lothar; Hebart Holger
Fludarabine may induce durable remission in patients with leptomeningeal involvement of chronic lymphocytic leukemia.
Leukemia & lymphoma 2005;46(11):1593-8.
2005: Herrlinger Ulrich; Hebart Holger; Kanz Lothar; Dichgans Johannes; Weller Michael
Relapse of primary CNS lymphoma after more than 10 years in complete remission.
Journal of neurology 2005;252(11):1409-10.
2005: Sökler Martin; Kanz Lothar
[Systemic mastocytosis]
Deutsche medizinische Wochenschrift (1946) 2005;Suppl 1():96.
2005: Haap Michael; Kötter Ina; Horger Marius; Thamer Claus; Wehrmann Manfred; Häring Hans-U; Kanz Lothar; Hartmann Jörg Thomas
Disseminated epitheloid hemangioendothelioma mimicking symptoms of systemic vasculitis.
Onkologie 2005;28(8-9):429-32.
2005: Lengerke Claudia; Wirths Stefan; Kanz Lothar; Hebart Holger; Kaiserling Edwin; Krober Stefan M; Horger Marius Stefan; Soennichsen Karsten
Unusual leukemia presentations. Case 1. Pulmonary chloroma preceded by leukemia cutis 7 years earlier.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5837-9.
2005: Hartmann Jörg Thomas; Rick Oliver; Oechsle Karin; Kuczyk Markus; Gauler Thomas; Schöffski Patrick; Schleicher Jan; Mayer Frank; Teichmann Reinhard; Kanz Lothar; Bokemeyer Carsten
Role of postchemotherapy surgery in the management of patients with liver metastases from germ cell tumors.
Annals of surgery 2005;242(2):260-6.
2005: Bartolovic Kerol; Balabanov Stefan; Berner Birgit; Bühring Hans-Jörg; Komor Martina; Becker Sven; Hoelzer Dieter; Kanz Lothar; Hofmann Wolf-Karsten; Brümmendorf Tim H
Clonal heterogeneity in growth kinetics of CD34+CD38- human cord blood cells in vitro is correlated with gene expression pattern and telomere length.
Stem cells (Dayton, Ohio) 2005;23(7):946-57.
2005: Balabanov S; Bartolovic K; Komor M; Kanz L; Hofmann W K; Brümmendorf T H
Gene expression profiling of normal hematopoietic progenitor cells under treatment with imatinib in vitro.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(8):1483-5.
2005: Kollmannsberger C; Budach W; Stahl M; Schleucher N; Hehr T; Wilke H; Schleicher J; Vanhoefer U; Jehle E C; Oechsle K; Trarbach T; Boehlke I; Kanz L; Hartmann J T; Bokemeyer C
Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(8):1326-33.
2005: Yildirim S; Boehmler A M; Kanz L; Möhle R
Expansion of cord blood CD34+ hematopoietic progenitor cells in coculture with autologous umbilical vein endothelial cells (HUVEC) is superior to cytokine-supplemented liquid culture.
Bone marrow transplantation 2005;36(1):71-9.
2005: Beier Fabian; Balabanov Stefan; Buckley Tom; Dietz Klaus; Hartmann Ulrike; Rojewski Markus; Kanz Lothar; Schrezenmeier Hubert; Brümmendorf Tim H
Accelerated telomere shortening in glycosylphosphatidylinositol (GPI)-negative compared with GPI-positive granulocytes from patients with paroxysmal nocturnal hemoglobinuria (PNH) detected by proaerolysin flow-FISH.
Blood 2005;106(2):531-3.
2005: Balabanov Stefan; Appel Silke; Kanz Lothar; Brossart Peter; Brümmendorf Tim H
Effect of tyrosine kinase inhibition using imatinib on normal lymphohematopoietic cells.
Annals of the New York Academy of Sciences 2005;1044():168-77.
2005: Seitz Gabriele; Boehmler Andreas M; Kanz Lothar; Möhle Robert
The role of sphingosine 1-phosphate receptors in the trafficking of hematopoietic progenitor cells.
Annals of the New York Academy of Sciences 2005;1044():84-9.
2005: Herrlinger Ulrich; Küker Wilhelm; Uhl Martin; Blaicher Hans-Peter; Karnath Hans-Otto; Kanz Lothar; Bamberg Michael; Weller Michael;
NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report.
Annals of neurology 2005;57(6):843-7.
2005: Weisel Katja C; Brümmendorf Tim H; Orlic Donald; Fibbe Willem E; Kanz Lothar
Meeting summary: International Symposium and Workshop on Hematopoietic Stem Cells V, University of Tübingen, Germany, September 16-18, 2004.
Experimental hematology 2005;33(5):513-22.
2005: Hartmann Ulrike; Balabanov Stefan; Ziegler Patrick; Fellenberg Jörg; van der Kuip Heiko; Duyster Justus; Lipp Hans-Peter; Bokemeyer Carsten; Kanz Lothar; Brümmendorf Tim H
Telomere length and telomerase activity in the BCR-ABL-transformed murine Pro-B cell line BaF3 is unaffected by treatment with imatinib.
Experimental hematology 2005;33(5):542-9.
2005: Daikeler T; Erley C; Mohren M; Amberger C; Einsele H; Kanz L; Kötter I
Fever and increasing cANCA titre after kidney and autologous stem cell transplantation for Wegener's granulomatosis.
Annals of the rheumatic diseases 2005;64(4):646-7.
2005: Wierecky J; Kollmannsberger C; Boehlke I; Kuczyk M; Schleicher J; Schleucher N; Metzner B; Kanz L; Hartmann J T; Bokemeyer C
Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer.
Journal of cancer research and clinical oncology 2005;131(4):255-60.
2005: Vogel Wichard; Kopp Hans-Georg; Kanz Lothar; Einsele Hermann
Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation.
Journal of cancer research and clinical oncology 2005;131(4):214-8.
2005: Lengerke C; Brümmendorf T; Herrlinger U; Horger M; Kanz L; Hartmann J T
Transient respiratory failure possibly associated to imatinib.
Investigational new drugs 2005;23(2):137-8.
2005: Sökler Martin; Kanz Lothar
[Systemic mastocytosis]
Deutsche medizinische Wochenschrift (1946) 2005;130(9):474.
2005: Herrlinger Ulrich; Korfel Agnieszka; Hebart Holger; Schlegel Uwe; Plasswilm Ludwig; Illerhaus Gerald; Finke Jürgen; Krüger William; Montemurro Michael; Wolf Timo; Thiel Eckhart; Bamberg Michael; Weller Michael; Kanz Lothar;
Meeting report: primary central nervous system lymphoma: standards of care and future perspectives.
Onkologie 2005;28(2):109-11.
2004: Reichardt Volker L; Brossart Peter; Kanz Lothar
Dendritic cells in vaccination therapies of human malignant disease.
Blood reviews 2004;18(4):235-43.
2004: Brugger W; Hirsch J; Grünebach F; Repp R; Brossart P; Vogel W; Kopp H-G; Manz M G; Bitzer M; Schlimok G; Kaufmann M; Ganser A; Fehnle K; Gramatzki M; Kanz L
Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(11):1691-8.
2004: Knop Stefan; Dohmen Bernhard M; Kanz Lothar; Bares Roland; Einsele Hermann
153 Samarium-EDTMP in myeloablative dosage followed by a second autotransplantation in patients with relapsed multiple myeloma.
Haematologica 2004;89(9):ECR36.
2004: Bokemeyer C; Kollmannsberger C; Stenning S; Hartmann J T; Horwich A; Clemm C; Gerl A; Meisner C; Rückerl C-P; Schmoll H-J; Kanz L; Oliver T
Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials.
British journal of cancer 2004;91(4):683-7.
2004: Kopp H-G; Kanz L; Hartmann J T
Hypersensitivity pneumonitis associated with the use of trofosfamide.
Anti-cancer drugs 2004;15(6):603-4.
2004: Hartmann Joerg Thomas; Oechsle Karin; Jäger Elke; Reis Hans Edgar; Haag Cornelie; Niederle Norbert; Wilke Hans-Joachim; Pflüger Karl-Heinz; Batran Salah Al; Büchele Thomas; Hofheinz Ralf D; Kanz Lothar; Bokemeyer Carsten
Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracil.
Anti-cancer drugs 2004;15(5):473-7.
2004: Kimura Takafumi; Boehmler Andreas M; Seitz Gabriele; Kuçi Selim; Wiesner Tina; Brinkmann Volker; Kanz Lothar; Möhle Robert
The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34+ progenitor cells.
Blood 2004;103(12):4478-86.
2004: Knop Stefan; Bux Juergen; Kroeber Stefan M; Bader Peter; Hebart Holger; Kanz Lothar; Einsele Hermann
Fatal immune-mediated pancytopenia and a TRALI-like syndrome associated with high titers of recipient-type antibodies against donor-derived peripheral blood cells after allogeneic bone marrow transplantation following dose reduced conditioning.
Haematologica 2004;89(5):ECR12.
2004: Scheding Stefan; Bergmannn Markus; Rathke Gisa; Vogel Wichard; Brugger Wolfram; Kanz Lothar
Additional transplantation of ex vivo generated megakaryocytic cells after high-dose chemotherapy.
Haematologica 2004;89(5):630-1.
2004: Mohren M; Daikeler T; Benz D; Günaydin I; Kanz L; Kötter I
Myeloablative immunosuppressive treatment with autologous haematopoietic stem cell transplantation in a patient with psoriatic arthropathy and monoclonal gammopathy of undetermined significance.
Annals of the rheumatic diseases 2004;63(4):466-7.
2004: Schmidt Susanne M; Schag Kerstin; Müller Martin R; Weinschenk Toni; Appel Silke; Schoor Oliver; Weck Markus M; Grünebach Frank; Kanz Lothar; Stevanovic Stefan; Rammensee Hans-Georg; Brossart Peter
Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysis.
Cancer research 2004;64(3):1164-70.
2004: Knop Stefan; Jakob Andreas; Kanz Lothar; Hebart Holger; Bares Roland; Dohmen Bernhard
186Rhenium-labeled anti-CD20 antibody radioimmunotherapy followed by autologous peripheral blood stem cell transplantation in patients with relapsed or refractory non-Hodgkin lymphoma.
Blood 2004;103(3):1175.
2004: Kollmannsberger C; Beyer J; Liersch R; Schoeffski P; Metzner B; Hartmann J T; Rick O; Stengele K; Hohloch K; Spott C; Kanz L; Bokemeyer C
Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):108-14.
2004: Appel Silke; Boehmler Andreas M; Grünebach Frank; Müller Martin R; Rupf Anette; Weck Markus M; Hartmann Ulrike; Reichardt Volker L; Kanz Lothar; Brümmendorf Tim H; Brossart Peter
Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells.
Blood 2004;103(2):538-44.
2004: Bartolovic Kerol; Balabanov Stefan; Hartmann Ulrike; Komor Martina; Boehmler Andreas M; Bühring Hans-Jörg; Möhle Robert; Hoelzer Dieter; Kanz Lothar; Hofmann Wolf-Karsten; Brümmendorf Tim H
Inhibitory effect of imatinib on normal progenitor cells in vitro.
Blood 2004;103(2):523-9.
2004: Weisel Katja C; Brugger Wolfram; Kröber Stefan M; Kaiserling Edwin; Kanz Lothar
Intravascular lymphoma - a rare cause of hemolytic anemia and neurologic disorders.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(5):444-6.
2003: Hartmann J T; Oechsle K; Quietzsch D; Wein A; Hofheinz R D; Honecker F; Nehls O; Köhne C-H; Käfer G; Kanz L; Bokemeyer C
Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study.
British journal of cancer 2003;89(11):2051-6.
2003: Krauter Jürgen; Gorlich Kerstin; Ottmann Oliver; Lubbert Michael; Dohner Hartmut; Heit Wolfgang; Kanz Lothar; Ganser Arnold; Heil Gerhard
Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(23):4413-22.
2003: Reichardt Peter; Oechsle Karin; Pink Daniel; Bokemeyer Carsten; Schneller F; Issels Rolf; Kanz Lothar; Hartmann Jörg Thomas
An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcoma.
Investigational new drugs 2003;21(4):481-6.
2003: Schmoll H-J; Kollmannsberger C; Metzner B; Hartmann J T; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel W E; Andreesen R; Bokemeyer C;
Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(22):4083-91.
2003: Reichardt Volker L; Milazzo Caterina; Brugger Wolfram; Einsele Hermann; Kanz Lothar; Brossart Peter
Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cells.
Haematologica 2003;88(10):1139-49.
2003: Wiesmann A; Bader P; Faul C; Schnaidt M; Kanz L; Einsele H
Successful haematopoietic stem cell transplantation from a matched unrelated donor following three graft failures from HLA-mismatched related donors.
Bone marrow transplantation 2003;32(7):729-31.
2003: Einsele H; Bamberg M; Budach W; Schmidberger H; Hess C F; Wörmann B; Meisner C; Straka C; Hebart H; Trümper L; Kröger N; Zander A R; Hegewisch-Becker S; Hossfeld D K; Schmidt H; Müller P; Schlimok G; Hertenstein B; Peest D; Metzner B; Frickhofen N; Kanz L; Bensinger W I
A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma.
Bone marrow transplantation 2003;32(6):593-9.
2003: Kugler Alexander; Stuhler Gernot; Walden Peter; Zöller Gerhard; Zobywalski Anke; Brossart Peter; Trefzer Uwe; Ullrich Silke; Müller Claudia A; Becker Volker; Gross Andreas J; Hemmerlein Bernhard; Kanz Lothar; Müller Gerhard A; Ringert Rolf-Hermann
Retraction: Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids.
Nature medicine 2003;9(9):1221.
2003: Wiesmann A; Bader P; Bamberg M; Faul C; Kanz L; Einsele H
Severe acute graft-versus-host disease after T-cell depleted allogeneic stem cell graft from a second donor caused by persisting T-cells from the first donor.
Bone marrow transplantation 2003;32(5):511-3.
2003: Müller Martin R; Grünebach Frank; Kayser Katrin; Vogel Wichard; Nencioni Alessio; Brugger Wolfram; Kanz Lothar; Brossart Peter
Expression of her-2/neu on acute lymphoblastic leukemias: implications for the development of immunotherapeutic approaches.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(9):3448-53.
2003: Scheding Stefan; Ersöz Inci; Hartmann Ulrike; Bartolvic Kerol; Balabanov Stefan; Salama Abdulgabar; Kanz Lothar; Brümmendorf Tim H
Peripheral blood cell telomere length measurements indicate that hematopoietic stem cell turnover is not significantly increased in whole blood and apheresis PLT donors.
Transfusion 2003;43(8):1089-95.
2003: Salih Helmut Rainer; Antropius Holger; Gieseke Friederike; Lutz Stefan Zoltan; Kanz Lothar; Rammensee Hans-Georg; Steinle Alexander
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia.
Blood 2003;102(4):1389-96.
2003: Bokemeyer C; Schleucher N; Metzner B; Thomas M; Rick O; Schmoll H-J; Kollmannsberger C; Boehlke I; Kanz L; Hartmann J T
First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial.
British journal of cancer 2003;89(1):29-35.
2003: Schmidt Susanne M; Schag Kerstin; Müller Martin R; Weck Markus M; Appel Silke; Kanz Lothar; Grünebach Frank; Brossart Peter
Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells.
Blood 2003;102(2):571-6.
2003: Brümmendorf Tim H; Orlic Donald; Fibbe Willem E; Sharkis Saul; Kanz Lothar
Meeting summary: International Symposium and Workshop on Hematopoietic Stem Cells IV, University of Tübingen, Germany, September 19-21, 2002.
Experimental hematology 2003;31(6):475-82.
2003: Herrlinger Ulrich; Schwärzler Frank; Beck Robert; Küker Wilhelm; Hebart Holger; Kanz Lothar; Dichgans Johannes; Weller Michael
Progressive multifocal leukoencephalopathy: cidofovir therapy in three patients with underlying hematological disease.
Journal of neurology 2003;250(5):612-4.
2003: Giesert Christina; Marxer Anke; Sutherland D Robert; Schuh Andre C; Kanz Lothar; Buhring Hans-Jorg
Antibody W7C5 defines a CD109 epitope expressed on CD34+ and CD34- hematopoietic and mesenchymal stem cell subsets.
Annals of the New York Academy of Sciences 2003;996():227-30.
2003: Conze Tim; Lammers Reiner; Kuci Selim; Scherl-Mostageer Marwa; Schweifer Norbert; Kanz Lothar; Buhring Hans-Jorg
CDCP1 is a novel marker for hematopoietic stem cells.
Annals of the New York Academy of Sciences 2003;996():222-6.
2003: Mohle Robert; Boehmler Andreas M; Denzlinger Claudio; Kanz Lothar
Nonpeptide mediators in the hematopoietic microenvironment.
Annals of the New York Academy of Sciences 2003;996():61-6.
2003: Brummendorf Tim H; Ersoz Inci; Hartmann Ulrike; Balabanov Stefan; Wolke Holger; Paschka Peter; Lahaye Tanja; Berner Birgit; Bartolovic Kerol; Kreil Sebastian; Berger Ute; Gschaidmeier Harald; Bokemeyer Carsten; Hehlmann Rudiger; Dietz Klaus; Lansdorp Peter M; Kanz Lothar; Hochhaus Andreas
Normalization of previously shortened telomere length under treatment with imatinib argues against a preexisting telomere length deficit in normal hematopoietic stem cells from patients with chronic myeloid leukemia.
Annals of the New York Academy of Sciences 2003;996():26-38.
2003: Einsele Hermann; Schäfer Hans-Jörg; Hebart Holger; Bader Peter; Meisner Christoph; Plasswilm Ludwig; Liebisch Peter; Bamberg Michael; Faul Christoph; Kanz Lothar
Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioning.
British journal of haematology 2003;121(3):411-8.
2003: Kollmannsberger C; Schleucher N; Rick O; Metzner B; Hartmann J T; Schöffski P; Beyer J; Casper J; Sosada M; Schmoll H-J; Böhlke I; Meisner C; Kanz L; Bokemeyer C
Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support.
European journal of cancer (Oxford, England : 1990) 2003;39(6):775-82.
2003: Hartmann J T; Oechsle K; Mayer F; Kanz L; Bokemeyer C
Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas.
Anticancer research 2003;23(2C):1899-901.
2003: Vogel Wichard; Grünebach Frank; Messam Conrad A; Kanz Lothar; Brugger Wolfram; Bühring Hans-Jörg
Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells.
Haematologica 2003;88(2):126-33.
2003: Bokemeyer Carsten; Hartmann Jorg T; Fossa Sophie D; Droz Jean-P; Schmol Hans-J; Horwich Alan; Gerl Arthur; Beyer Jorg; Pont Jorg; Kanz Lothar; Nichols Craig R; Einhorn Lawrence
Extragonadal germ cell tumors: relation to testicular neoplasia and management options.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2003;111(1):49-59; discussion 59-63.
2003: Brümmendorf Tim H; Ersöz Inci; Hartmann Ulrike; Bartolovic Kerol; Balabanov Stefan; Wahl Alexandra; Paschka Peter; Kreil Sebastian; Lahaye Tanja; Berger Ute; Gschaidmeier Harald; Bokemeyer Carsten; Hehlmann Rüdiger; Dietz Klaus; Lansdorp Peter M; Kanz Lothar; Hochhaus Andreas
Telomere length in peripheral blood granulocytes reflects response to treatment with imatinib in patients with chronic myeloid leukemia.
Blood 2003;101(1):375-6.
2003: Treusch Michaela; Stübiger Nicole; Vonthein Reinhard; Baur Manuela; Koch Silvia; Günaydin Ilhan; Kanz Lothar; Zierhut Manfred; Kötter Ina
Influence of interferon-alpha on lymphocyte subpopulations in Behçet's disease.
Advances in experimental medicine and biology 2003;528():533-5.
2003: Kötter Ina; Zierhut Manfred; Eckstein Anja; Vonthein Reinhard; Ness Thomas; Günaydin Ilhan; Grimbacher Bodo; Blaschke Sabine; Peter Hans-Hartmut; Kanz Lothar; Stübiger Nicole
Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis.
Advances in experimental medicine and biology 2003;528():521-3.
2003: Kötter Ina; Günaydin Ilhan; Treusch Michaela; Zierhut Manfred; Kanz Lothar; Stübiger Nicole
The use of interferon-alpha in Behçet's disease--review of the literature and possible mechanisms of action.
Advances in experimental medicine and biology 2003;528():503-9.
2003: Kötter Ina; Vonthein Reinhard; Günaydin Ilhan; Müller Claudia; Kanz Lothar; Zierhut Manfred; Stübiger Nicole
Behçet's disease in patients of German and Turkish origin--a comparative study.
Advances in experimental medicine and biology 2003;528():53-8.
2003: Boehmler Andreas M; Denzlinger Claudio; Kanz Lothar; Möhle Robert
Potential role of cysteinyl leukotrienes in trafficking and survival of hematopoietic progenitor cells.
Advances in experimental medicine and biology 2003;525():25-8.
2002: Bokemeyer C; Oechsle K; Hartmann J T; Schöffski P; Schleucher N; Metzner B; Schleicher J; Kanz L
Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer.
British journal of cancer 2002;87(10):1066-71.
2002: Bokemeyer C; Kanz L
[Allogeneic hematopoetic cell transplantation in patients with solid tumors - Contra]
Deutsche medizinische Wochenschrift (1946) 2002;127(42):2215.
2002: Wiesmann Anne; Weissert Robert; Kanz Lothar; Einsele Hermann
Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stem cell transplantation.
Blood 2002;100(7):2679-80.
2002: Kollmannsberger C; Rick O; Klaproth H; Kubin T; Sayer H G; Hentrich M; Welslau M; Mayer F; Kuczyk M; Spott C; Kanz L; Bokemeyer C
Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group.
British journal of cancer 2002;87(7):729-32.
2002: Plasswilm L; Herrlinger U; Korfel A; Weller M; Küker W; Kanz L; Thiel E; Bamberg M
Primary central nervous system (CNS) lymphoma in immunocompetent patients.
Annals of hematology 2002;81(8):415-23.
2002: Hartmann J T; Nichols C R; Droz J-P; Horwich A; Gerl A; Fossa S D; Beyer J; Pont J; Kanz L; Einhorn L; Bokemeyer C
Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(7):1017-28.
2002: Vogel W; Kopp H G; Kanz L; Einsele H
Correlations between hematopoietic progenitor cell counts as measured by Sysmex and CD34+ cell harvest yields following mobilization with different regimens.
Journal of cancer research and clinical oncology 2002;128(7):380-4.
2002: Kollmannsberger C; Mayer F; Pressler H; Koch S; Kanz L; Oosterhuis J W; Looijenga L H J; Bokemeyer C
Absence of c-KIT and members of the epidermal growth factor receptor family in refractory germ cell cancer.
Cancer 2002;95(2):301-8.
2002: Honecker F; Kollmannsberger C; Quietzsch D; Haag C; Schroeder M; Spott C; Hartmann J T; Baronius W; Hempel V; Kanz L; Bokemeyer C
Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer.
Anti-cancer drugs 2002;13(5):497-503.
2002: Einsele Hermann; Roosnek Eddy; Rufer Nathalie; Sinzger Christian; Riegler Susanne; Löffler Jürgen; Grigoleit Ulrich; Moris Arnaud; Rammensee Hans-Georg; Kanz Lothar; Kleihauer Annette; Frank Friederike; Jahn Gerhard; Hebart Holger
Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy.
Blood 2002;99(11):3916-22.
2002: Mayer F; Hartmann J T; von Pawel J; Beck J; Schroeder M; Boehlke I; Kanz L; Bokemeyer C;
A phase I study of oral uracil-ftorafur plus folinic acid in combination with weekly paclitaxel in patients with solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(5):755-9.
2002: Kollmannsberger Christian; Oechsle Karin; Dohmen Bernhard M; Pfannenberg Anna; Bares Roland; Claussen Claus D; Kanz Lothar; Bokemeyer Carsten
Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma.
Cancer 2002;94(9):2353-62.
2002: Hebart Holger; Daginik Senay; Stevanovic Stefan; Grigoleit Ulrich; Dobler Andrea; Baur Manuela; Rauser Georg; Sinzger Christian; Jahn Gerhard; Loeffler Juergen; Kanz Lothar; Rammensee Hans-Georg; Einsele Hermann
Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation.
Blood 2002;99(10):3830-7.
2002: Jakob A; Bokemeyer C; Knop S; Schupp M; Mayer F; Kanz L
Capecitabine in patients with breast cancer relapsing after high-dose chemotherapy plus autologous peripheral stem cell transplantation--a phase II study.
Anti-cancer drugs 2002;13(4):405-10.
2002: Kollmannsberger C; Rick O; Derigs H-G; Schleucher N; Schöffski P; Beyer J; Schoch R; Sayer H G; Gerl A; Kuczyk M; Spott C; Kanz L; Bokemeyer C
Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2031-7.
2002: Bokemeyer Carsten; Nichols Craig R; Droz Jean-P; Schmoll Hans-J; Horwich Alan; Gerl Arthur; Fossa Sophie D; Beyer Jörg; Pont Jörg; Kanz Lothar; Einhorn Lawrence; Hartmann Jörg T
Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1864-73.
2002: Scheding Stefan; Bergmann Markus; Shimosaka Akihiro; Wolff Philipp; Driessen Christoph; Rathke Gisa; Jaschonek Karl; Brugger Wolfram; Kanz Lothar
Human plasma thrombopoietin levels are regulated by binding to platelet thrombopoietin receptors in vivo.
Transfusion 2002;42(3):321-7.
2002: Manz Markus G; Berger Christoph; Horny Hans-Peter; Beck Robert; Brugger Wolfram; Viebahn Richard; Kanz Lothar; Knecht Hans
Sustained remission of an extensive monoclonal, Epstein-Barr virus-associated diffuse large B cell lymphoma in a kidney-pancreas transplant recipient.
Transplantation 2002;73(6):995-7.
2002: Bokemeyer C; Kollmannsberger C; Oechsle K; Dohmen B M; Pfannenberg A; Claussen C D; Bares R; Kanz L
Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET.
British journal of cancer 2002;86(4):506-11.
2002: Herrlinger Ulrich; Schabet Martin; Brugger Wolfram; Kortmann Rolf-Dieter; Küker Wilhelm; Deckert Martina; Engel Corinna; Schmeck-Lindenau Hans-Jürgen; Mergenthaler Hans-Günther; Krauseneck Peter; Benöhr Christian; Meisner Christoph; Wiestler Otmar D; Dichgans Johannes; Kanz Lothar; Bamberg Michael; Weller Michael
German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma.
Annals of neurology 2002;51(2):247-52.
2002: Lang Karl S; Roll Benjamin; Myssina Svetlana; Schittenhelm Markus; Scheel-Walter Hans-Gerhard; Kanz Lothar; Fritz Jasmin; Lang Florian; Huber Stephan M; Wieder Thomas
Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2002;12(5-6):365-72.
2001: Stilz R; Grünebach F; Bader P; Vogel W; Kanz L; Brugger W; Scheding S
Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging.
Journal of hematotherapy & stem cell research 2001;10(6):777-85.
2001: Hartmann J T; Fossa S D; Nichols C R; Droz J P; Horwich A; Gerl A; Beyer J; Pont J; Fizazi K; Hecker H; Kanz L; Einhorn L; Bokemeyer C
Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors.
Journal of the National Cancer Institute 2001;93(22):1733-8.
2001: Brossart P; Wirths S; Brugger W; Kanz L
Dendritic cells in cancer vaccines.
Experimental hematology 2001;29(11):1247-55.
2001: Brossart P; Schneider A; Dill P; Schammann T; Grünebach F; Wirths S; Kanz L; Bühring H J; Brugger W
The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes.
Cancer research 2001;61(18):6846-50.
2001: Schäfer H; Berger C; Aepinus C; Hebart H; Beck R; Kaiserling E; Kanz L; Einsele H; Knecht H
Molecular pathogenesis of Epstein-Barr virus associated posttransplant lymphomas: new insights through latent membrane protein 1 fingerprinting.
Transplantation 2001;72(3):492-6.
2001: Brümmendorf T H; Orlic D; Sharkis S J; Kanz L
Meeting summary: International Symposium and Workshop on Hematopoietic Stem Cells III, University of Tübingen, Germany, September 14-16, 2000.
Experimental hematology 2001;29(7):797-802.
2001: Brugger W; Schneider A; Schammann T; Dill P; Grünebach F; Bühring H J; Kanz L; Brossart P
Dendritic cell-based vaccines in patients with hematological malignancies.
Annals of the New York Academy of Sciences 2001;938():359-62; discussion 362-3.
2001: Möhle R; Bautz F; Denzlinger C; Kanz L
Transendothelial migration of hematopoietic progenitor cells. Role of chemotactic factors.
Annals of the New York Academy of Sciences 2001;938():26-34; discussion 34-5.
2001: Giesert C; Almeida-Porada G; Scheffold A; Kanz L; Zanjani E D; Bühring H J
The monoclonal antibody W7C5 defines a novel surface antigen on hematopoietic stem cells.
Annals of the New York Academy of Sciences 2001;938():175-83.
2001: Bokemeyer C; Gillis A J; Pompe K; Mayer F; Metzner B; Schleucher N; Schleicher J; Pflugrad-Jauch G; Oosterhuis J W; Kanz L; Looijenga L H
Clinical impact of germ cell tumor cells in apheresis products of patients receiving high-dose chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(12):3029-36.
2001: Bautz F; Denzlinger C; Kanz L; Möhle R
Chemotaxis and transendothelial migration of CD34(+) hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1.
Blood 2001;97(11):3433-40.
2001: Bühring H J; Seiffert M; Giesert C; Marxer A; Kanz L; Valent P; Sano K
The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3.
Blood 2001;97(10):3303-5.
2001: Seiffert M; Brossart P; Cant C; Cella M; Colonna M; Brugger W; Kanz L; Ullrich A; Bühring H J
Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells.
Blood 2001;97(9):2741-9.
2001: Kollmannsberger C; Mayer F; Kuczyk M; Kanz L; Bokemeyer C
Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy.
World journal of urology 2001;19(2):120-5.
2001: Kleihauer A; Grigoleit U; Hebart H; Moris A; Brossart P; Muhm A; Stevanovic S; Rammensee H G; Sinzger C; Riegler S; Jahn G; Kanz L; Einsele H
Ex vivo generation of human cytomegalovirus-specific cytotoxic T cells by peptide-pulsed dendritic cells.
British journal of haematology 2001;113(1):231-9.
2001: Manz M; Riessen R; Poll L; Dohmen B; Kaiserling E; Krück W; Laniado M; Kanz L; Denzlinger C
High-grade lymphoma mimicking bone crisis in Gaucher's disease.
British journal of haematology 2001;113(1):191-3.
2001: Hebart H; Brugger W; Grigoleit U; Gscheidle B; Loeffler J; Schäfer H; Kanz L; Einsele H; Sinzger C
Risk for cytomegalovirus disease in patients receiving polymerase chain reaction-based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality.
Blood 2001;97(7):2183-5.
2001: Bokemeyer C; Droz J P; Horwich A; Gerl A; Fossa S D; Beyer J; Pont J; Schmoll H J; Kanz L; Einhorn L; Nichols C R; Hartmann J T
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome.
Cancer 2001;91(7):1394-401.
2001: Hartmann J T; Einhorn L; Nichols C R; Droz J P; Horwich A; Gerl A; Fossa S D; Beyer J; Pont J; Schmoll H J; Kanz L; Bokemeyer C
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1641-8.
2001: Hartmann J T; von Vangerow A; Fels L M; Knop S; Stolte H; Kanz L; Bokemeyer C
A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplantation.
British journal of cancer 2001;84(3):313-20.
2001: Herrlinger U; Schabet M; Brugger W; Kortmann R D; Kanz L; Bamberg M; Dichgans J; Weller M
Primary central nervous system lymphoma 1991-1997: outcome and late adverse effects after combined modality treatment.
Cancer 2001;91(1):130-5.
2001: Rick O; Bokemeyer C; Beyer J; Hartmann J T; Schwella N; Kingreen D; Neureither S; Metzner B; Casper J; Wandt H; Hartmann F; Schmoll H J; Derigs G; Gerl A; Berdel W E; Kanz L; Siegert W
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):81-8.
2001: Kötter I; Aepinus C; Graepler F; Gärtner V; Eckstein A K; Stübiger N; Kaskas B; Zierhut M; Bültmann B; Kandolf R; Kanz L
HHV8 associated Kaposi's sarcoma during triple immunosuppressive treatment with cyclosporin A, azathioprine, and prednisolone for ocular Behçet's disease and complete remission of both disorders with interferon alpha.
Annals of the rheumatic diseases 2001;60(1):83-6.
2000: Hebart H; Löffler J; Reitze H; Engel A; Schumacher U; Klingebiel T; Bader P; Böhme A; Martin H; Bunjes D; Kern W V; Kanz L; Einsele H
Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia.
British journal of haematology 2000;111(2):635-40.
2000: Brossart P; Wirths S; Stuhler G; Reichardt V L; Kanz L; Brugger W
Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells.
Blood 2000;96(9):3102-8.
2000: Bokemeyer C; Hartmann J T; Mayer F; Böhlke I; Kanz L; Von Pawel J; Derigs G; Schröder M
UFT/leucovorin plus weekly paclitaxel in the treatment of solid tumors.
Oncology (Williston Park, N.Y.) 2000;14(10 Suppl 9):63-7.
2000: Hartmann J T; Fels L M; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
Anticancer research 2000;20(5C):3767-73.
2000: Kollmannsberger C; Nichols C; Meisner C; Mayer F; Kanz L; Bokemeyer C
Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: an explorative analysis using cart modeling.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(9):1115-20.
2000: Möhle R; Schittenhelm M; Failenschmid C; Bautz F; Kratz-Albers K; Serve H; Brugger W; Kanz L
Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia.
British journal of haematology 2000;110(3):563-72.
2000: Kollmannsberger C; Gerl A; Schleucher N; Beyer J; Kuczyk M; Rick O; Casper J; Sosada M; Rie C; Kanz L; Bokemeyer C
Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer.
Anti-cancer drugs 2000;11(7):535-9.
2000: Brossart P; Zobywalski A; Grünebach F; Behnke L; Stuhler G; Reichardt V L; Kanz L; Brugger W
Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.
Cancer research 2000;60(16):4485-92.
2000: Hartmann J T; Fels L M; Knop S; Stolt H; Kanz L; Bokemeyer C
A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors.
Investigational new drugs 2000;18(3):281-9.
2000: Kollmannsberger C; Quietzsch D; Haag C; Lingenfelser T; Schroeder M; Hartmann J T; Baronius W; Hempel V; Clemens M; Kanz L; Bokemeyer C
A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer.
British journal of cancer 2000;83(4):458-62.
2000: Bautz F; Rafii S; Kanz L; Möhle R
Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells. Possible role in the hematopoietic microenvironment.
Experimental hematology 2000;28(6):700-6.
2000: Hartmann J T; Nichols C R; Droz J P; Horwich A; Gerl A; Fossa S D; Beyer J; Pont J; Einhorn L; Kanz L; Bokemeyer C
The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors.
Cancer 2000;88(11):2629-35.
2000: Kollmannsberger C; Nichols C; Bamberg M; Hartmann J T; Schleucher N; Beyer J; Schöfski P; Derigs G; Rüther U; Böhlke I; Schmoll H J; Kanz L; Bokemeyer C
First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(5):553-9.
2000: Hebart H; Löffler J; Meisner C; Serey F; Schmidt D; Böhme A; Martin H; Engel A; Bunje D; Kern W V; Schumacher U; Kanz L; Einsele H
Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening.
The Journal of infectious diseases 2000;181(5):1713-9.
2000: Braun N; Faul C; Wernet D; Schnaidt M; Stuhler G; Kanz L; Risler T; Einsele H
Successful transplantation of highly selected CD34+ peripheral blood stem cells in a HLA-sensitized patient treated with immunoadsorption onto protein A.
Transplantation 2000;69(8):1742-4.
2000: Scheding S; Meister B; Bühring H J; Baum C M; Mc Kearn J P; Bock T; Kanz L; Brugger W
Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells.
Experimental hematology 2000;28(4):460-70.
2000: Einsele H; Hebart H; Kauffmann-Schneider C; Sinzger C; Jahn G; Bader P; Klingebiel T; Dietz K; Löffler J; Bokemeyer C; Müller C A; Kanz L
Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection.
Bone marrow transplantation 2000;25(7):757-63.
2000: Hartmann J T; Kanz L; Bokemeyer C
Phase II study of continuous 120-hour-infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma.
Anticancer research 2000;20(2B):1177-82.
2000: Bethge W; Guggenberger D; Bamberg M; Kanz L; Bokemeyer C
Thyroid toxicity of treatment for Hodgkin's disease.
Annals of hematology 2000;79(3):114-8.
2000: Kratz-Albers K; Scheding S; Möhle R; Bühring H J; Baum C M; Mc Kearn J P; Büchner T; Kanz L; Brugger W
Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34(+) cells with stem cell factor and promegapoietin.
Experimental hematology 2000;28(3):335-46.
2000: Kugler A; Stuhler G; Walden P; Zöller G; Zobywalski A; Brossart P; Trefzer U; Ullrich S; Müller C A; Becker V; Gross A J; Hemmerlein B; Kanz L; Müller G A; Ringert R H
Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids.
Nature medicine 2000;6(3):332-6.
2000: Günaydin I; Pereira P L; Daikeler T; Mohren M; Trübenbach J; Schick F; Kanz L; Kötter I
Magnetic resonance imaging guided corticosteroid injection of the sacroiliac joints in patients with therapy resistant spondyloarthropathy: a pilot study.
The Journal of rheumatology 2000;27(2):424-8.
2000: Hartmann J T; Knop S; Fels L M; van Vangerow A; Stolte H; Kanz L; Bokemeyer C
The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumors.
Anti-cancer drugs 2000;11(1):1-6.
2000: Brugger W; Scheding S; Ziegler B; Bühring H J; Kanz L
Ex vivo manipulation of hematopoietic stem and progenitor cells.
Seminars in hematology 2000;37(1 Suppl 2):42-9.
2000: Denzlinger C; Bowen D; Benz D; Gelly K; Brugger W; Kanz L
Low-dose melphalan induces favourable responses in elderly patients with high-risk myelodysplastic syndromes or secondary acute myeloid leukaemia.
British journal of haematology 2000;108(1):93-5.
2000: Hartmann J T; Nichols C R; Droz J P; Horwich A; Gerl A; Fossa S D; Beyer J; Pont J; Fizazi K; Einhorn L; Kanz L; Bokemeyer C
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors.
Journal of the National Cancer Institute 2000;92(1):54-61.
2000: Bokemeyer C; Kollmannsberger C; Hartmann J T; Kanz L
Follow up after primary treatment: curable diseases treated non-surgically.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11 Suppl 3():73-8.
2000: Vogel W; Scheding S; Kanz L; Brugger W
Clinical applications of CD34(+) peripheral blood progenitor cells (PBPC).
Stem cells (Dayton, Ohio) 2000;18(2):87-92.
1999: Einsele H; Kanz L
[Allogeneic transplantation of stem cells]
Der Internist 1999;40(12):1249-56.
1999: Bethge W; Beck R; Jahn G; Mundinger P; Kanz L; Einsele H
Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantation.
Bone marrow transplantation 1999;24(11):1245-8.
1999: Brossart P; Spahlinger B; Grünebach F; Stuhler G; Reichardt V L; Kanz L; Brugger
Induction of minor histocompatiblity antigen HA-1-specific cytotoxic T cells for the treatment of leukemia after allogeneic stem cell transplantation.
Blood 1999;94(12):4374-6.
1999: Möhle R; Failenschmid C; Bautz F; Kanz L
Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(12):1954-9.
1999: Hartmann J T; Kollmannsberger C; Kanz L; Bokemeyer C
Platinum organ toxicity and possible prevention in patients with testicular cancer.
International journal of cancer. Journal international du cancer 1999;83(6):866-9.
1999: Kollmannsberger C; Hartmann J T; Kanz L; Bokemeyer C
Therapy-related malignancies following treatment of germ cell cancer.
International journal of cancer. Journal international du cancer 1999;83(6):860-3.
1999: Bokemeyer C; Kollmannsberger C; Harstrick A; Beyer J; Gerl A; Casper J; Metzner B; Hartmann J T; Schmoll H J; Kanz L
Treatment of patients with cisplatin-refractory testicular germ-cell cancer. German Testicular Cancer Study Group (GTCSG).
International journal of cancer. Journal international du cancer 1999;83(6):848-51.
1999: Kollmannsberger C; Kuzcyk M; Mayer F; Hartmann J T; Kanz L; Bokemeyer C
Late toxicity following curative treatment of testicular cancer.
Seminars in surgical oncology 1999;17(4):275-81.
1999: Seiffert M; Cant C; Chen Z; Rappold I; Brugger W; Kanz L; Brown E J; Ullrich A; Bühring H J
Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47.
Blood 1999;94(11):3633-43.
1999: Kollmannsberger C; Pressler H; Mayer F; Kanz L; Bokemeyer C
Cisplatin-refractory, HER2/neu-expressing germ-cell cancer: induction of remission by the monoclonal antibody Trastuzumab.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1393-4.
1999: Bokemeyer C; Kollmannsberger C; Meisner C; Harstrick A; Beyer J; Metzner B; Hartmann J T; Schmoll H J; Einhorn L; Kanz L; Nichols C
First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(11):3450-6.
1999: Hartmann J T; Kuczyk M A; Kollmannsberger C; Kanz L; Bokemeyer C
Future prospects in the chemotherapy of metastatic nonseminomatous testicular germ-cell cancer.
World journal of urology 1999;17(5):324-33.
1999: Bühring H J; Simmons P J; Pudney M; Müller R; Jarrossay D; van Agthoven A; Willheim M; Brugger W; Valent P; Kanz L
The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors.
Blood 1999;94(7):2343-56.
1999: Hartmann J T; Quietzsch D; Daikeler T; Kollmannsberger C; Mayer F; Kanz L; Bokemeyer C
Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer.
Anti-cancer drugs 1999;10(8):729-33.
1999: Hartmann J T; Kanz L; Bokemeyer C
Diagnosis and treatment of patients with testicular germ cell cancer.
Drugs 1999;58(2):257-81.
1999: Bokemeyer C; Hartmann J T; Kollmannsberger C; Mayer F; Kanz L
UFT/calcium folinate plus weekly paclitaxel for solid tumors.
Oncology (Williston Park, N.Y.) 1999;13(7 Suppl 3):106-11.
1999: Bühring H J; Seiffert M; Marxer A; Weiss B; Faul C; Kanz L; Brugger W
AC133 antigen expression is not restricted to acute myeloid leukemia blasts but is also found on acute lymphoid leukemia blasts and on a subset of CD34+ B-cell precursors.
Blood 1999;94(2):832-3.
1999: Kollmannsberger C; Brugger W; Hartmann J T; Maurer F; Böhm P; Kanz L; Bokemeyer C
Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma.
Anti-cancer drugs 1999;10(5):453-6.
1999: Brossart P; Heinrich K S; Stuhler G; Behnke L; Reichardt V L; Stevanovic S; Muhm A; Rammensee H G; Kanz L; Brugger W
Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies.
Blood 1999;93(12):4309-17.
1999: Fetscher S; Brugger W; Engelhardt R; Kanz L; Hasse J; Frommhold H; Lange W; Mertelsmann R
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 107 patients with non-small-cell lung cancer: a mature follow-up report.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(5):605-7.
1999: Fetscher S; Brugger W; Engelhardt R; Kanz L; Hasse J; Frommhold H; Lange W; Mertelsmann R
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(5):561-7.
1999: Scheding S; Franke H; Diehl V; Wichmann H E; Brugger W; Kanz L; Schmitz S
How many myeloid post-progenitor cells have to be transplanted to completely abrogate neutropenia after peripheral blood progenitor cell transplantation? Results of a computer simulation.
Experimental hematology 1999;27(5):956-65.
1999: Brugger W; Bühring H J; Grünebach F; Vogel W; Kaul S; Müller R; Brümmendorf T H; Ziegler B L; Rappold I; Brossart P; Scheding S; Kanz L
Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1535-44.
1999: Ziegler B L; Müller R; Valtieri M; Lamping C P; Thomas C A; Gabbianelli M; Giesert C; Bühring H J; Kanz L; Peschle C
Unicellular-unilineage erythropoietic cultures: molecular analysis of regulatory gene expression at sibling cell level.
Blood 1999;93(10):3355-68.
1999: Brugger W; Brossart P; Scheding S; Stuhler G; Heinrich K; Reichardt V; Grünebach F; Bühring H J; Kanz L
Approaches to dendritic cell-based immunotherapy after peripheral blood stem cell transplantation.
Annals of the New York Academy of Sciences 1999;872():363-71.
1999: Bock T A; Ziegler B L; Bühring H J; Scheding S; Brugger W; Kanz L
Characterization of purified and ex vivo manipulated human hematopoietic progenitor and stem cells in xenograft recipients.
Annals of the New York Academy of Sciences 1999;872():200-7; discussion 207-10.
1999: Möhle R; Bautz F; Rafii S; Moore M A; Brugger W; Kanz L
Regulation of transendothelial migration of hematopoietic progenitor cells.
Annals of the New York Academy of Sciences 1999;872():176-85; discussion 185-6.
1999: Bühring H J; Seiffert M; Bock T A; Scheding S; Thiel A; Scheffold A; Kanz L; Brugger W
Expression of novel surface antigens on early hematopoietic cells.
Annals of the New York Academy of Sciences 1999;872():25-38; discussion 38-9.
1999: Bock T A; Scheding S; Brugger W; Kanz L
Clinical use for expanded peripheral blood stem cells.
Baillière's best practice & research. Clinical haematology 1999;12(1-2):117-28.
1999: Meister B; Grünebach F; Bautz F; Brugger W; Fink F M; Kanz L; Möhle R
Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma.
European journal of cancer (Oxford, England : 1990) 1999;35(3):445-9.
1999: Bokemeyer C; Gerl A; Schöffski P; Harstrick A; Niederle N; Beyer J; Casper J; Schmoll H J; Kanz L
Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):512-6.
1999: Stuhler G; Zobywalski A; Grünebach F; Brossart P; Reichardt V L; Barth H; Stevanovic S; Brugger W; Kanz L; Schlossman S F
Immune regulatory loops determine productive interactions within human T lymphocyte-dendritic cell clusters.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(4):1532-5.
1999: Daikeler T; Günaydin I; Einsele H; Kanz L; Kötter I
Transmission of psoriatic arthritis by allogeneic bone marrow transplantation for chronic myelogenous leukaemia from an HLA-identical donor.
Rheumatology (Oxford, England) 1999;38(1):89-90.
1999: Wiesmann A; Weller A; Lischka G; Klingebiel T; Kanz L; Einsele H
Treatment of acute graft-versus-host disease with PUVA (psoralen and ultraviolet irradiation): results of a pilot study.
Bone marrow transplantation 1999;23(2):151-5.
1999: Handgretinger R; Geiselhart A; Moris A; Grau R; Teuffel O; Bethge W; Kanz L; Fisch P
Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors.
The New England journal of medicine 1999;340(4):278-84.
1999: Günaydin I; Terhorst T; Eckstein A; Daikeler T; Kanz L; Kötter I
Assessment of keratoconjunctivitis sicca in patients with fibromyalgia: results of a prospective study.
Rheumatology international 1999;19(1-2):7-9.
1999: Günaydin I; Daikeler T; Mohren M; Kanz L; Kötter I
Lower limb pitting edema in systemic lupus erythematosus.
Rheumatology international 1999;18(4):159-60.
1999: Kollmannsberger C; Mross K; Jakob A; Kanz L; Bokemeyer C
Topotecan - A novel topoisomerase I inhibitor: pharmacology and clinical experience.
Oncology 1999;56(1):1-12.
1998: Bowen D T; Denzlinger C; Brugger W; Culligan D; Gelly K; Adlakha S; Groves M; Hepburn M; Kanz L
Poor response rate to a continuous schedule of Amifostine therapy for 'low/intermediate risk' myelodysplastic patients.
British journal of haematology 1998;103(3):785-7.
1998: Brossart P; Grünebach F; Stuhler G; Reichardt V L; Möhle R; Kanz L; Brugger W
Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor.
Blood 1998;92(11):4238-47.
1998: Jakob A; Kollmannsberger C; Kanz L; Bokemeyer C
[Late toxicity after chemotherapy of malignant testicular tumors]
Der Urologe. Ausg. A 1998;37(6):635-47.
1998: Ziegler B L; Kanz L
Expansion of stem and progenitor cells.
Current opinion in hematology 1998;5(6):434-40.
1998: Kollmannsberger C; Beyer J; Droz J P; Harstrick A; Hartmann J T; Biron P; Fléchon A; Schöffski P; Kuczyk M; Schmoll H J; Kanz L; Bokemeyer C
Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3386-91.
1998: Wiesmann A; Pereira P; Böhm P; Faul C; Kanz L; Einsele H
Avascular necrosis of bone following allogeneic stem cell transplantation: MR screening and therapeutic options.
Bone marrow transplantation 1998;22(6):565-9.
1998: Scheding S; Kratz-Albers K; Meister B; Brugger W; Kanz L
Ex vivo expansion of hematopoietic progenitor cells for clinical use.
Seminars in hematology 1998;35(3):232-40.
1998: Hartmann J T; Köhne C H; Schmoll H J; Daikeler T; Kanz L; Bokemeyer C
Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II study.
Oncology 1998;55(4):320-5.
1998: Hartmann J T; Harstrick A; Daikeler T; Kollmannsberger C; Müller C; Seeber S; Kanz L; Bokemeyer C
Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancer.
Anti-cancer drugs 1998;9(5):427-31.
1998: Möhle R; Bautz F; Rafii S; Moore M A; Brugger W; Kanz L
The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1.
Blood 1998;91(12):4523-30.
1998: Hebart H; Gamer D; Loeffler J; Mueller C; Sinzger C; Jahn G; Bader P; Klingebiel T; Kanz L; Einsele H
Evaluation of Murex CMV DNA hybrid capture assay for detection and quantitation of cytomegalovirus infection in patients following allogeneic stem cell transplantation.
Journal of clinical microbiology 1998;36(5):1333-7.
1998: Bokemeyer C; Berger C C; Hartmann J T; Kollmannsberger C; Schmoll H J; Kuczyk M A; Kanz L
Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.
British journal of cancer 1998;77(8):1355-62.
1998: Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann J T; Holstein K; Derigs H G; de Wit R; Casper J; Schöffski P; Kührer I; Illiger H J; Kempf B; Reichle A; Föller A; Hossfeld D K; Fischer J T; Berdel W E; Gerhartz H H; Kirchner H; Pflüger K H; Ostermann H; Kanz L; Schmoll H J
The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
Seminars in oncology 1998;25(2 Suppl 4):24-32; discussion 45-8.
1998: Brugger W; Fetscher S; Hasse J; Frommhold H; Pressler K; Mertelsmann R; Engelhardt R; Kanz L
Multimodality treatment including early high-dose chemotherapy with peripheral blood stem cell transplantation in limited-disease small cell lung cancer.
Seminars in oncology 1998;25(1 Suppl 2):42-8.
1998: Brossart P; Stuhler G; Flad T; Stevanovic S; Rammensee H G; Kanz L; Brugger W
Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
Cancer research 1998;58(4):732-6.
1998: Jakob A; Kanz L
[Diagnostic criteria in polycythemia vera]
Deutsche medizinische Wochenschrift (1946) 1998;123(1-2):30-1.
1998: Hebart H; Kanz L; Jahn G; Einsele H
Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects.
Drugs 1998;55(1):59-72.
1998: Bokemeyer C; Hartmann J T; Kuczyk M A; Truss M C; Kollmannsberger C; Beyer J; Jonas U; Kanz L
Recent strategies for the use of paclitaxel in the treatment of urological malignancies.
World journal of urology 1998;16(2):155-62.
1998: Kanz L; Brugger W; Scheding S
Ex vivo manipulation of hematopoietic stem and progenitor cells.
Stem cells (Dayton, Ohio) 1998;16 Suppl 1():199-204.
1998: Günaydin I; Daikeler T; Jacki S; Mohren M; Kanz L; Kötter I
Articular involvement in patients with relapsing polychondritis.
Rheumatology international 1998;18(3):93-6.
1998: Kollmannsberger C; Hartmann J T; Kanz L; Bokemeyer C
Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies.
Journal of cancer research and clinical oncology 1998;124(3-4):207-14.
1998: Günaydin I; Kötter I; Jacki S; Daikeler T; Kanz L
Collagenous colitis associated with rheumatoid arthritis and anticardiolipin antibodies.
Clinical rheumatology 1998;17(1):79-80.
1997: Bokemeyer C; Hartmann J T; Lampe C S; Clemens M R; Quietzsch D; Forkmann L; Kanz L
Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer.
Seminars in oncology 1997;24(6 Suppl 19):S19-96-S19-100.
1997: Kanz L
[High dose therapy and stem cell transplantation. A new path in tumor therapy]
Der Internist 1997;38(11):1045-9.
1997: Fetscher S; Brugger W; Bertz H; Krieger G; Kanz L; Mertelsmann R; Lange W
High-dose chemotherapy with autologous peripheral blood stem cell transplantation for metastatic gastric leiomyosarcoma.
Bone marrow transplantation 1997;20(9):787-8.
1997: Bokemeyer C; Franzke A; Hartmann J T; Schöber C; Arseniev L; Metzner B; Link H; Kanz L; Schmoll H J
A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas.
Cancer 1997;80(7):1221-7.
1997: Daikeler T; Maas K; Hartmann J T; Kanz L; Bokemeyer C
Weekly short infusions of gemcitabine are not associated with suppression of lymphatic activity in patients with solid tumors.
Anti-cancer drugs 1997;8(6):643-4.
1997: Rappold I; Ziegler B L; Köhler I; Marchetto S; Rosnet O; Birnbaum D; Simmons P J; Zannettino A C; Hill B; Neu S; Knapp W; Alitalo R; Alitalo K; Ullrich A; Kanz L; Bühring H J
Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase.
Blood 1997;90(1):111-25.
1997: Hebart H; Schröder A; Löffler J; Klingebiel T; Martin H; Wassmann B; Gerneth F; Rabenau H; Jahn G; Kanz L; Müller C A; Einsele H
Cytomegalovirus monitoring by polymerase chain reaction of whole blood samples from patients undergoing autologous bone marrow or peripheral blood progenitor cell transplantation.
The Journal of infectious diseases 1997;175(6):1490-3.
1997: Einsele H; Hebart H; Roller G; Löffler J; Rothenhofer I; Müller C A; Bowden R A; van Burik J; Engelhard D; Kanz L; Schumacher U
Detection and identification of fungal pathogens in blood by using molecular probes.
Journal of clinical microbiology 1997;35(6):1353-60.
1997: Dimeo F C; Tilmann M H; Bertz H; Kanz L; Mertelsmann R; Keul J
Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation.
Cancer 1997;79(9):1717-22.
1997: Bokemeyer C; Lampe C S; Clemens M R; Hartmann J T; Quietzsch D; Forkmann L; Kollmannsberger C; Kanz L
A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil/folinic acid in patients with advanced gastric cancer.
Anti-cancer drugs 1997;8(4):396-9.
1997: Fetscher S; Lübbert M; Kanz L; Behringer D; Finke J; Mertelsmann R; Lange W
Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation.
Bone marrow transplantation 1997;19(5):527-8.
1997: Fetscher S; Brugger W; Engelhardt R; Kanz L; Hasse J; Frommhold H; Wenger M; Lange W; Mertelsmann R
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(1):57-64.
1997: Fetscher S; Brugger W; Engelhardt R; Kanz L; Hasse J; Frommhold H; Wenger M; Lange W; Mertelsmann R
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(1):49-56.
1997: Brugger W; Scheding S; Bock T; Ziegler B; Kanz L
Purging of peripheral blood progenitor cell autografts and treatment of minimal residual disease.
Stem cells (Dayton, Ohio) 1997;15 Suppl 1():159-65.
1996: Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt R M; Kanz L; Mertelsmann R
Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
Bone marrow transplantation 1996;18(6):1081-6.
1996: Hebart H; Einsele H; Klein R; Fischer I; Bühler S; Dietz K; Jahn G; Berg P A; Kanz L; Müller C A
CMV infection after allogeneic bone marrow transplantation is associated with the occurrence of various autoantibodies and monoclonal gammopathies.
British journal of haematology 1996;95(1):138-44.
1996: Vogel W; Behringer D; Scheding S; Kanz L; Brugger W
Ex vivo expansion of CD34+ peripheral blood progenitor cells: implications for the expansion of contaminating epithelial tumor cells.
Blood 1996;88(7):2707-13.
1996: Brugger W; Scheding S; Vogel W; Bock T; Bühring H J; Ziegler B; Kanz L
Ex vivo manipulations of CD34+ peripheral blood progenitor cells.
Bone marrow transplantation 1996;18 Suppl 1():S5-7.
1996: Maas K; Daikeler T; Kanz L; Bokemeyer C
Activity of gemcitabine in platinum-resistant ovarian germ cell cancer.
European journal of cancer (Oxford, England : 1990) 1996;32A(8):1437-8.
1996: Brugger W; Kanz L
Ex vivo expansion of hematopoietic precursor cells.
Current opinion in hematology 1996;3(3):235-40.
1996: Hebart H; Erley C; Kaskas B; Mayer R; König M; Einsele H; Bokemeyer C; Meerpohl H G; Feine U; Kanz L
Positron emission tomography helps to diagnose tumor emboli and residual disease in choriocarcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(4):416-8.
1996: Fisch P; Köhler G; Garbe A; Herbst B; Wider D; Kohler H; Schaefer H E; Mertelsmann R; Brugger W; Kanz L
Generation of antigen-presenting cells for soluble protein antigens ex vivo from peripheral blood CD34+ hematopoietic progenitor cells in cancer patients.
European journal of immunology 1996;26(3):595-600.
1996: Rosnet O; Bühring H J; Marchetto S; Rappold I; Lavagna C; Sainty D; Arnoulet C; Chabannon C; Kanz L; Hannum C; Birnbaum D
Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(2):238-48.
1996: Lübbert M; Brugger W; Mertelsmann R; Kanz L
Developmental regulation of myeloid gene expression and demethylation during ex vivo culture of peripheral blood progenitor cells.
Blood 1996;87(2):447-55.
1996: Bokemeyer C; Hartmann J T; Kuczyk M A; Truss M C; Beyer J; Jonas U; Kanz L
The role of paclitaxel in chemosensitive urological malignancies: current strategies in bladder cancer and testicular germ-cell tumors.
World journal of urology 1996;14(6):354-9.
1996: Bokemeyer C; Kuczyk M A; Serth J; Hartmann J T; Schmoll H J; Jonas U; Kanz L
Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parameters.
Journal of cancer research and clinical oncology 1996;122(10):575-84.
1996: Brugger W; Scheding S; Vogel W; Kanz L
Purging of peripheral blood progenitor cells.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7 Suppl 2():11-3.
1995: von Laer D; Meyer-Koenig U; Serr A; Finke J; Kanz L; Fauser A A; Neumann-Haefelin D; Brugger W; Hufert F T
Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrow.
Blood 1995;86(11):4086-90.
1995: Brugger W; Heimfeld S; Berenson R J; Mertelsmann R; Kanz L
Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo.
The New England journal of medicine 1995;333(5):283-7.
1995: Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
Seminars in oncology 1995;22(1 Suppl 2):3-8.
1994: Brugger W; Engelhardt R; Mertelsmann R; Kanz L
The management of primary mediastinal B-cell lymphoma with sclerosis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(10):943-7.
1994: Kanz L; Brugger W; Mertelsmann R
The use of hematopoietic growth factors for high-dose chemotherapy and peripheral blood progenitor cell transplantation.
Seminars in oncology 1994;21(6 Suppl 16):10-8.
1994: Henschler R; Brugger W; Luft T; Frey T; Mertelsmann R; Kanz L
Maintenance of transplantation potential in ex vivo expanded CD34(+)-selected human peripheral blood progenitor cells.
Blood 1994;84(9):2898-903.
1994: Brugger W; Henschler R; Heimfeld S; Berenson R J; Mertelsmann R; Kanz L
Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin.
Blood 1994;84(5):1421-6.
1994: Brugger W; Bross K J; Glatt M; Weber F; Mertelsmann R; Kanz L
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors.
Blood 1994;83(3):636-40.
1994: Scheding S; Brugger W; Mertelsmann R; Kanz L
Peripheral blood stem cells: in vivo biology and therapeutic potential.
Stem cells (Dayton, Ohio) 1994;12 Suppl 1():203-10; discussion 211.
1994: Fetscher S; Brugger W; Mertelsmann R; Kanz L
The clinical role of hematopoietic growth factors in peripheral blood progenitor cell transplantation.
Vox sanguinis 1994;67 Suppl 3():43-7.
1993: Brugger W; Birken R; Bertz H; Hecht T; Pressler K; Frisch J; Schulz G; Mertelsmann R; Kanz L
Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin.
British journal of haematology 1993;84(3):402-7.
1993: Brugger W; Mertelsmann R; Kanz L
Mobilization, purification and ex vivo expansion of human peripheral blood progenitor cells.
Nouvelle revue française d'hématologie 1993;35(3):221-3.
1993: Brugger W; Möcklin W; Heimfeld S; Berenson R J; Mertelsmann R; Kanz L
Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin.
Blood 1993;81(10):2579-84.
1993: Kanz L; Brugger W; Mertelsmann R
Haematopoietic growth factors and peripheral blood stem cells as supportive agents in dose intensification.
European journal of cancer (Oxford, England : 1990) 1993;29A Suppl 5():S23-6.
1992: Brugger W; Frisch J; Schulz G; Pressler K; Mertelsmann R; Kanz L
Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following standard-dose combination chemotherapy with etoposide, ifosfamide, and cisplatin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(9):1452-9.
1992: Herrmann F; Brugger W; Kanz L; Mertelsmann R
In vivo biology and therapeutic potential of hematopoietic growth factors and circulating progenitor cells.
Seminars in oncology 1992;19(4):422-31.
1992: Ganser A; Lindemann A; Ottmann O G; Seipelt G; Hess U; Geissler G; Kanz L; Frisch J; Schulz G; Herrmann F
Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I study.
Blood 1992;79(10):2583-91.
1992: Brugger W; Bross K J; Lindemann A; Kanz L; Mertelsmann R
Role of hematopoietic growth factor combinations in experimental and clinical oncology.
Seminars in oncology 1992;19(2 Suppl 4):8-15.
1992: Brugger W; Bross K; Frisch J; Dern P; Weber B; Mertelsmann R; Kanz L
Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin.
Blood 1992;79(5):1193-200.
1992: Frisch J; Ganser A; Hoelzer D; Brugger W; Kanz L; Mertelsmann R; Schulz G
Interleukin-3 and granulocyte-macrophage colony-stimulating factor in combination: clinical implication.
Medical and pediatric oncology. Supplement 1992;2():34-7.
1991: Kanz L; Brugger W; Bross K; Mertelsmann R
Combination of cytokines: current status and future prospects.
British journal of haematology 1991;79 Suppl 1():96-104.
1991: Lange W; Luig A; Dölken G; Mertelsmann R; Kanz L
Fibrinogen gamma-chain mRNA is not detected in human megakaryocytes.
Blood 1991;78(1):20-5.
1991: Lange W; Brugger W; Rosenthal F M; Kanz L; Lindemann A
The role of cytokines in oncology.
International journal of cell cloning 1991;9(4):252-73.
1991: Kanz L; Lindemann A; Oster W; Herrmann F; Mertelsmann R
Hemopoietins in clinical oncology.
American journal of clinical oncology 1991;14 Suppl 1():S27-33.
1991: Brugger W; Rosenthal F M; Kanz L; Mertelsmann R
Clinical role of colony stimulating factors.
Acta haematologica 1991;86(3):138-47.
1990: Kanz L; Mertelsmann R
[Proliferation and differentiation in megakaryopoiesis]
Verhandlungen der Deutschen Gesellschaft für Pathologie 1990;74():28-35.
1988: Kanz L; Mielke R; Fauser A A
Analysis of human hemopoietic progenitor cells for the expression of glycoprotein IIIa.
Experimental hematology 1988;16(9):741-7.
1988: Kanz L; Mielke R; Fauser A A; Löhr G W
Evaluation of c-sis mRNA expression by human megakaryocytic cells in normals and patients with myeloproliferative disorders.
Advances in experimental medicine and biology 1988;241():73-80.

Sign-in to see more